Loading…

BRCA2 promoter polymorphism is associated with breast cancer prognosis in Chinese women

Background Breast cancer 2 (BRCA2) is an important breast cancer-susceptibility gene.Promoter polymorphisms in BRCA2 may affect its transcription and be associated with cancer prognosis.Methods We identified five polymorphisms of the BRCA2 promoter region by in silico searching and direct sequencing...

Full description

Saved in:
Bibliographic Details
Published in:Chinese medical journal 2014, Vol.127 (11), p.2012-2015
Main Authors: Liu, Lu, Fang, Yi, Fan, Jianlin, Hu, Jianming, Xu, Xiaoting, Jin, Xiaohong, Wang, Xiuzhen, Deng, Min, Wang, Jing, Liu, Wei
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c437t-88d3c1fb84a1d9a87b6dcb4a71e0a50d80ee4fbb147e232b7abd451842128d753
cites cdi_FETCH-LOGICAL-c437t-88d3c1fb84a1d9a87b6dcb4a71e0a50d80ee4fbb147e232b7abd451842128d753
container_end_page 2015
container_issue 11
container_start_page 2012
container_title Chinese medical journal
container_volume 127
creator Liu, Lu
Fang, Yi
Fan, Jianlin
Hu, Jianming
Xu, Xiaoting
Jin, Xiaohong
Wang, Xiuzhen
Deng, Min
Wang, Jing
Liu, Wei
description Background Breast cancer 2 (BRCA2) is an important breast cancer-susceptibility gene.Promoter polymorphisms in BRCA2 may affect its transcription and be associated with cancer prognosis.Methods We identified five polymorphisms of the BRCA2 promoter region by in silico searching and direct sequencing:-254A/G (rs3092989),-908A/G (rs206117),-1134A/G (rs206115),-1144C/T (rs206116),and-1260CTTAGA/-(rs3072036).The-908A/G,-1134A/G,-1144C/T,and-1260CTTAGA/-polymorphisms were genotyped by direct sequencing in 491 breast cancer patients,and the-254A/G polymorphism was genotyped by Sequenom.Results The-1144C/T polymorphism was associated with clinical outcome.Carriers of the TT genotype had longer disease-free intervals (DFIs,P=0.029),especially among patients with sporadic unilateral breast cancer (P=0.010).Linkage disequilibrium (LD) analysis showed that all the five single nucleotide polymorphisms (SNPs) were in LD (D'〉0.8).Carriers of haplotypes containing the-1144T allele showed longer DFIs (P=0.049),and the result was more significant in patients with sporadic unilateral cancer (P=0.018).There were no significant associations between the other polymorphisms and DFI.Conclusions The results of this study suggest that homozygosity for the BRCA2 T(-1144) allele is associated with a longer DFI in Chinese women with breast cancer.Further functional studies are warranted to clarify this relationship.
doi_str_mv 10.3760/cma.j.issn.0366-6999.20130978
format article
fullrecord <record><control><sourceid>wanfang_jour_proqu</sourceid><recordid>TN_cdi_wanfang_journals_zhcmj201411003</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>49969228</cqvip_id><wanfj_id>zhcmj201411003</wanfj_id><sourcerecordid>zhcmj201411003</sourcerecordid><originalsourceid>FETCH-LOGICAL-c437t-88d3c1fb84a1d9a87b6dcb4a71e0a50d80ee4fbb147e232b7abd451842128d753</originalsourceid><addsrcrecordid>eNo9kU1v1DAYhC0EotuWv4DMAcQlwV-J7QOHdkUBqRISatWjZTvOxtHG3tpZrcqvx9Hu9vRennlnNAPAZ4xqylv0zU66Hmufc6gRbduqlVLWBGGKJBdvwIo0jFRNy_BbsHoFLsBlziNCpGl4-x5cECYkwoyuwNPt3_UNgbsUpzi7BHdx-zLFtBt8nqDPUOccrdez6-DBzwM0yek8Q6uDXegUNyHmwvkA14MPLjt4iJML1-Bdr7fZfTjdK_B49-Nh_au6__Pz9_rmvrKM8rkSoqMW90YwjTupBTdtZw3THDukG9QJ5BzrjcGMO0KJ4dp0rMGCEUxExxt6Bb4c_x506HXYqDHuUyiO6t9gp7EUwzBGiBbw6xEsmZ_3Ls9q8tm67VYHF_dZ4YYSxjmhvKDfj6hNMefkerVLftLpRWGklhFUGUGNahlBLR2rpWN1HqHoP56s9mZy3av63HoBPp0Mhhg2z77EPjNMylYSIuh_sVKRsw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1532477237</pqid></control><display><type>article</type><title>BRCA2 promoter polymorphism is associated with breast cancer prognosis in Chinese women</title><source>LWW_医学期刊</source><creator>Liu, Lu ; Fang, Yi ; Fan, Jianlin ; Hu, Jianming ; Xu, Xiaoting ; Jin, Xiaohong ; Wang, Xiuzhen ; Deng, Min ; Wang, Jing ; Liu, Wei</creator><creatorcontrib>Liu, Lu ; Fang, Yi ; Fan, Jianlin ; Hu, Jianming ; Xu, Xiaoting ; Jin, Xiaohong ; Wang, Xiuzhen ; Deng, Min ; Wang, Jing ; Liu, Wei</creatorcontrib><description>Background Breast cancer 2 (BRCA2) is an important breast cancer-susceptibility gene.Promoter polymorphisms in BRCA2 may affect its transcription and be associated with cancer prognosis.Methods We identified five polymorphisms of the BRCA2 promoter region by in silico searching and direct sequencing:-254A/G (rs3092989),-908A/G (rs206117),-1134A/G (rs206115),-1144C/T (rs206116),and-1260CTTAGA/-(rs3072036).The-908A/G,-1134A/G,-1144C/T,and-1260CTTAGA/-polymorphisms were genotyped by direct sequencing in 491 breast cancer patients,and the-254A/G polymorphism was genotyped by Sequenom.Results The-1144C/T polymorphism was associated with clinical outcome.Carriers of the TT genotype had longer disease-free intervals (DFIs,P=0.029),especially among patients with sporadic unilateral breast cancer (P=0.010).Linkage disequilibrium (LD) analysis showed that all the five single nucleotide polymorphisms (SNPs) were in LD (D'〉0.8).Carriers of haplotypes containing the-1144T allele showed longer DFIs (P=0.049),and the result was more significant in patients with sporadic unilateral cancer (P=0.018).There were no significant associations between the other polymorphisms and DFI.Conclusions The results of this study suggest that homozygosity for the BRCA2 T(-1144) allele is associated with a longer DFI in Chinese women with breast cancer.Further functional studies are warranted to clarify this relationship.</description><identifier>ISSN: 0366-6999</identifier><identifier>EISSN: 2542-5641</identifier><identifier>DOI: 10.3760/cma.j.issn.0366-6999.20130978</identifier><identifier>PMID: 24890143</identifier><language>eng</language><publisher>China: Department of Pathology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China%Department of Abdominal Surgical Oncology, Cancer Hospital, Peking Union Medical College &amp; Chinese Academy of Medical Sciences, Beijing 100021, China%Department of Stomatology, Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, China%Department of Obstetrics and Gynaecology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China%Department of Radiation Oncology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China%Department of Anesthesiology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China%Department of Pathology, Soochow University, Suzhou, Jiangsu 215006, China</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Asian Continental Ancestry Group - genetics ; BRCA2 ; Breast Neoplasms - genetics ; Breast Neoplasms - pathology ; Female ; Genetic Predisposition to Disease - genetics ; Genotype ; Haplotypes ; Humans ; Linkage Disequilibrium ; Middle Aged ; Polymorphism, Single Nucleotide - genetics ; Promoter Regions, Genetic - genetics ; 中国 ; 乳腺癌 ; 单核苷酸多态性 ; 基因启动子区 ; 女性 ; 直接测序 ; 预后</subject><ispartof>Chinese medical journal, 2014, Vol.127 (11), p.2012-2015</ispartof><rights>Copyright © Wanfang Data Co. Ltd. All Rights Reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c437t-88d3c1fb84a1d9a87b6dcb4a71e0a50d80ee4fbb147e232b7abd451842128d753</citedby><cites>FETCH-LOGICAL-c437t-88d3c1fb84a1d9a87b6dcb4a71e0a50d80ee4fbb147e232b7abd451842128d753</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/85656X/85656X.jpg</thumbnail><link.rule.ids>314,780,784,4022,27922,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24890143$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liu, Lu</creatorcontrib><creatorcontrib>Fang, Yi</creatorcontrib><creatorcontrib>Fan, Jianlin</creatorcontrib><creatorcontrib>Hu, Jianming</creatorcontrib><creatorcontrib>Xu, Xiaoting</creatorcontrib><creatorcontrib>Jin, Xiaohong</creatorcontrib><creatorcontrib>Wang, Xiuzhen</creatorcontrib><creatorcontrib>Deng, Min</creatorcontrib><creatorcontrib>Wang, Jing</creatorcontrib><creatorcontrib>Liu, Wei</creatorcontrib><title>BRCA2 promoter polymorphism is associated with breast cancer prognosis in Chinese women</title><title>Chinese medical journal</title><addtitle>Chinese Medical Journal</addtitle><description>Background Breast cancer 2 (BRCA2) is an important breast cancer-susceptibility gene.Promoter polymorphisms in BRCA2 may affect its transcription and be associated with cancer prognosis.Methods We identified five polymorphisms of the BRCA2 promoter region by in silico searching and direct sequencing:-254A/G (rs3092989),-908A/G (rs206117),-1134A/G (rs206115),-1144C/T (rs206116),and-1260CTTAGA/-(rs3072036).The-908A/G,-1134A/G,-1144C/T,and-1260CTTAGA/-polymorphisms were genotyped by direct sequencing in 491 breast cancer patients,and the-254A/G polymorphism was genotyped by Sequenom.Results The-1144C/T polymorphism was associated with clinical outcome.Carriers of the TT genotype had longer disease-free intervals (DFIs,P=0.029),especially among patients with sporadic unilateral breast cancer (P=0.010).Linkage disequilibrium (LD) analysis showed that all the five single nucleotide polymorphisms (SNPs) were in LD (D'〉0.8).Carriers of haplotypes containing the-1144T allele showed longer DFIs (P=0.049),and the result was more significant in patients with sporadic unilateral cancer (P=0.018).There were no significant associations between the other polymorphisms and DFI.Conclusions The results of this study suggest that homozygosity for the BRCA2 T(-1144) allele is associated with a longer DFI in Chinese women with breast cancer.Further functional studies are warranted to clarify this relationship.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Asian Continental Ancestry Group - genetics</subject><subject>BRCA2</subject><subject>Breast Neoplasms - genetics</subject><subject>Breast Neoplasms - pathology</subject><subject>Female</subject><subject>Genetic Predisposition to Disease - genetics</subject><subject>Genotype</subject><subject>Haplotypes</subject><subject>Humans</subject><subject>Linkage Disequilibrium</subject><subject>Middle Aged</subject><subject>Polymorphism, Single Nucleotide - genetics</subject><subject>Promoter Regions, Genetic - genetics</subject><subject>中国</subject><subject>乳腺癌</subject><subject>单核苷酸多态性</subject><subject>基因启动子区</subject><subject>女性</subject><subject>直接测序</subject><subject>预后</subject><issn>0366-6999</issn><issn>2542-5641</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNo9kU1v1DAYhC0EotuWv4DMAcQlwV-J7QOHdkUBqRISatWjZTvOxtHG3tpZrcqvx9Hu9vRennlnNAPAZ4xqylv0zU66Hmufc6gRbduqlVLWBGGKJBdvwIo0jFRNy_BbsHoFLsBlziNCpGl4-x5cECYkwoyuwNPt3_UNgbsUpzi7BHdx-zLFtBt8nqDPUOccrdez6-DBzwM0yek8Q6uDXegUNyHmwvkA14MPLjt4iJML1-Bdr7fZfTjdK_B49-Nh_au6__Pz9_rmvrKM8rkSoqMW90YwjTupBTdtZw3THDukG9QJ5BzrjcGMO0KJ4dp0rMGCEUxExxt6Bb4c_x506HXYqDHuUyiO6t9gp7EUwzBGiBbw6xEsmZ_3Ls9q8tm67VYHF_dZ4YYSxjmhvKDfj6hNMefkerVLftLpRWGklhFUGUGNahlBLR2rpWN1HqHoP56s9mZy3av63HoBPp0Mhhg2z77EPjNMylYSIuh_sVKRsw</recordid><startdate>2014</startdate><enddate>2014</enddate><creator>Liu, Lu</creator><creator>Fang, Yi</creator><creator>Fan, Jianlin</creator><creator>Hu, Jianming</creator><creator>Xu, Xiaoting</creator><creator>Jin, Xiaohong</creator><creator>Wang, Xiuzhen</creator><creator>Deng, Min</creator><creator>Wang, Jing</creator><creator>Liu, Wei</creator><general>Department of Pathology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China%Department of Abdominal Surgical Oncology, Cancer Hospital, Peking Union Medical College &amp; Chinese Academy of Medical Sciences, Beijing 100021, China%Department of Stomatology, Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, China%Department of Obstetrics and Gynaecology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China%Department of Radiation Oncology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China%Department of Anesthesiology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China%Department of Pathology, Soochow University, Suzhou, Jiangsu 215006, China</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>2B.</scope><scope>4A8</scope><scope>92I</scope><scope>93N</scope><scope>PSX</scope><scope>TCJ</scope></search><sort><creationdate>2014</creationdate><title>BRCA2 promoter polymorphism is associated with breast cancer prognosis in Chinese women</title><author>Liu, Lu ; Fang, Yi ; Fan, Jianlin ; Hu, Jianming ; Xu, Xiaoting ; Jin, Xiaohong ; Wang, Xiuzhen ; Deng, Min ; Wang, Jing ; Liu, Wei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c437t-88d3c1fb84a1d9a87b6dcb4a71e0a50d80ee4fbb147e232b7abd451842128d753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Asian Continental Ancestry Group - genetics</topic><topic>BRCA2</topic><topic>Breast Neoplasms - genetics</topic><topic>Breast Neoplasms - pathology</topic><topic>Female</topic><topic>Genetic Predisposition to Disease - genetics</topic><topic>Genotype</topic><topic>Haplotypes</topic><topic>Humans</topic><topic>Linkage Disequilibrium</topic><topic>Middle Aged</topic><topic>Polymorphism, Single Nucleotide - genetics</topic><topic>Promoter Regions, Genetic - genetics</topic><topic>中国</topic><topic>乳腺癌</topic><topic>单核苷酸多态性</topic><topic>基因启动子区</topic><topic>女性</topic><topic>直接测序</topic><topic>预后</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liu, Lu</creatorcontrib><creatorcontrib>Fang, Yi</creatorcontrib><creatorcontrib>Fan, Jianlin</creatorcontrib><creatorcontrib>Hu, Jianming</creatorcontrib><creatorcontrib>Xu, Xiaoting</creatorcontrib><creatorcontrib>Jin, Xiaohong</creatorcontrib><creatorcontrib>Wang, Xiuzhen</creatorcontrib><creatorcontrib>Deng, Min</creatorcontrib><creatorcontrib>Wang, Jing</creatorcontrib><creatorcontrib>Liu, Wei</creatorcontrib><collection>维普_期刊</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>维普中文医药期刊数据库</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Wanfang Data Journals - Hong Kong</collection><collection>WANFANG Data Centre</collection><collection>Wanfang Data Journals</collection><collection>万方数据期刊 - 香港版</collection><collection>China Online Journals (COJ)</collection><collection>China Online Journals (COJ)</collection><jtitle>Chinese medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Lu</au><au>Fang, Yi</au><au>Fan, Jianlin</au><au>Hu, Jianming</au><au>Xu, Xiaoting</au><au>Jin, Xiaohong</au><au>Wang, Xiuzhen</au><au>Deng, Min</au><au>Wang, Jing</au><au>Liu, Wei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>BRCA2 promoter polymorphism is associated with breast cancer prognosis in Chinese women</atitle><jtitle>Chinese medical journal</jtitle><addtitle>Chinese Medical Journal</addtitle><date>2014</date><risdate>2014</risdate><volume>127</volume><issue>11</issue><spage>2012</spage><epage>2015</epage><pages>2012-2015</pages><issn>0366-6999</issn><eissn>2542-5641</eissn><abstract>Background Breast cancer 2 (BRCA2) is an important breast cancer-susceptibility gene.Promoter polymorphisms in BRCA2 may affect its transcription and be associated with cancer prognosis.Methods We identified five polymorphisms of the BRCA2 promoter region by in silico searching and direct sequencing:-254A/G (rs3092989),-908A/G (rs206117),-1134A/G (rs206115),-1144C/T (rs206116),and-1260CTTAGA/-(rs3072036).The-908A/G,-1134A/G,-1144C/T,and-1260CTTAGA/-polymorphisms were genotyped by direct sequencing in 491 breast cancer patients,and the-254A/G polymorphism was genotyped by Sequenom.Results The-1144C/T polymorphism was associated with clinical outcome.Carriers of the TT genotype had longer disease-free intervals (DFIs,P=0.029),especially among patients with sporadic unilateral breast cancer (P=0.010).Linkage disequilibrium (LD) analysis showed that all the five single nucleotide polymorphisms (SNPs) were in LD (D'〉0.8).Carriers of haplotypes containing the-1144T allele showed longer DFIs (P=0.049),and the result was more significant in patients with sporadic unilateral cancer (P=0.018).There were no significant associations between the other polymorphisms and DFI.Conclusions The results of this study suggest that homozygosity for the BRCA2 T(-1144) allele is associated with a longer DFI in Chinese women with breast cancer.Further functional studies are warranted to clarify this relationship.</abstract><cop>China</cop><pub>Department of Pathology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China%Department of Abdominal Surgical Oncology, Cancer Hospital, Peking Union Medical College &amp; Chinese Academy of Medical Sciences, Beijing 100021, China%Department of Stomatology, Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, China%Department of Obstetrics and Gynaecology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China%Department of Radiation Oncology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China%Department of Anesthesiology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China%Department of Pathology, Soochow University, Suzhou, Jiangsu 215006, China</pub><pmid>24890143</pmid><doi>10.3760/cma.j.issn.0366-6999.20130978</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0366-6999
ispartof Chinese medical journal, 2014, Vol.127 (11), p.2012-2015
issn 0366-6999
2542-5641
language eng
recordid cdi_wanfang_journals_zhcmj201411003
source LWW_医学期刊
subjects Adult
Aged
Aged, 80 and over
Asian Continental Ancestry Group - genetics
BRCA2
Breast Neoplasms - genetics
Breast Neoplasms - pathology
Female
Genetic Predisposition to Disease - genetics
Genotype
Haplotypes
Humans
Linkage Disequilibrium
Middle Aged
Polymorphism, Single Nucleotide - genetics
Promoter Regions, Genetic - genetics
中国
乳腺癌
单核苷酸多态性
基因启动子区
女性
直接测序
预后
title BRCA2 promoter polymorphism is associated with breast cancer prognosis in Chinese women
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T16%3A28%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wanfang_jour_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=BRCA2%20promoter%20polymorphism%20is%20associated%20with%20breast%20cancer%20prognosis%20in%20Chinese%20women&rft.jtitle=Chinese%20medical%20journal&rft.au=Liu,%20Lu&rft.date=2014&rft.volume=127&rft.issue=11&rft.spage=2012&rft.epage=2015&rft.pages=2012-2015&rft.issn=0366-6999&rft.eissn=2542-5641&rft_id=info:doi/10.3760/cma.j.issn.0366-6999.20130978&rft_dat=%3Cwanfang_jour_proqu%3Ezhcmj201411003%3C/wanfang_jour_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c437t-88d3c1fb84a1d9a87b6dcb4a71e0a50d80ee4fbb147e232b7abd451842128d753%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1532477237&rft_id=info:pmid/24890143&rft_cqvip_id=49969228&rft_wanfj_id=zhcmj201411003&rfr_iscdi=true